Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | CFTR | P13569 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | MYC | P01106 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL5610312 | 0.94 | TSHR (0.46) | TSHRLMNAALDH1A1HSD17B10CFTR | |
| SCHEMBL1513963 | 0.93 | TSHR (0.53) | TSHRLMNAALDH1A1HSD17B10KMT2A | |
| SCHEMBL1513969 | 0.86 | ALDH1A1 (0.56) | TSHRLMNAALDH1A1HSD17B10KMT2A | |
| SCHEMBL10591636 | 0.86 | TSHR (0.52) | TSHRLMNAALDH1A1HSD17B10KDM4E | |
| SCHEMBL28699777 | 0.85 | TSHR (0.70) | TSHRLMNAALDH1A1HSD17B10KDM4E | |
| SCHEMBL28362466 | 0.83 | LMNA (0.55) | TSHRLMNAALDH1A1HSD17B10KMT2A | |
| SCHEMBL27637585 | 0.83 | SMN1; SMN2 (0.48) | TSHRLMNAALDH1A1HSD17B10KMT2A | |
| SCHEMBL27583153 | 0.83 | UTS2R (0.48) | TSHRLMNAALDH1A1HSD17B10KMT2A | |
| SCHEMBL3110030 | 0.81 | ALDH1A1 (0.60) | TSHRALDH1A1HSD17B10CFTRKMT2A | |
| SCHEMBL11329828 | 0.81 | PTPN2 (0.43) | TSHRLMNAALDH1A1HSD17B10KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3697389-B1 | SUSTAINED RELEASE FORMULATIONS OF CROCUS SATIVUS | COUNCIL SCIENT IND RES (IN) | 2025-08-20 | — | — | EP | claimed |
| US-20250242031-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | PURDUE RESEARCH FOUNDATION | 2025-07-31 | — | — | US | claimed |
| EP-4479092-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | Purdue Research Foundation (US) | 2024-12-25 | — | — | EP | claimed |
| WO-2023154171-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | PURDUE RESEARCH FOUNDATION (US) | 2023-08-17 | — | — | WO | claimed |
| US-20200390843-A1 | SUSTAINED RELEASE FORMULATIONS OF CROCUS SATIVUS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2020-12-17 | — | — | US | claimed |
| US-10758490-B2 | Nanocapsules containing microemulsions | LIPOTEC, S.A. (ES) | 2020-09-01 | — | — | US | claimed |
| EP-3697389-A1 | SUSTAINED RELEASE FORMULATIONS OFCROCUS SATIVUS | Council of Scientific and Industrial Research (IN) | 2020-08-26 | — | — | EP | claimed |
| CN-104783123-B | Prebiotics low sodium salt and preparation method thereof | 四川亿生元科技有限公司 | 2020-03-27 | — | — | CN | claimed |
| CN-110772647-A | Capsule for carrying medicine for iodic contrast and preparation method thereof | 河北医科大学 | 2020-02-11 | — | — | CN | claimed |
| EP-2618926-B1 | NANOCAPSULES CONTAINING MICROEMULSIONS | LIPOTEC SA (ES) | 2019-05-08 | — | — | EP | claimed |
| WO-2005089720-A1 | VALSARTAN TABLETS AND THE PROCESS FOR THE PREPARATION THEREOF | RANBAXY LABORATORIES LIMITED (IN) | 2005-09-29 | — | — | WO | claimed |
| WO-2005082330-A2 | CO-PRECIPITATED AMORPHOUS CEFDITOREN PIVOXIL AND DOSAGE FORMS COMPRISING THE SAME | RANBAXY LABORATORIES LIMITED (IN) | 2005-09-09 | — | — | WO | claimed |
| EP-1545473-A2 | MODIFIED RELEASE, MULTIPLE UNIT DRUG DELIVERY SYSTEMS | RANBAXY LABORATORIES, LTD. (IN) | 2005-06-29 | — | — | EP | claimed |
| WO-2003103637-A2 | MODIFIED RELEASE, MULTIPLE UNIT DRUG DELIVERY SYSTEMS | RANBAXY LABORATORIES LIMITED (IN) | 2003-12-18 | — | — | WO | claimed |
| EP-1185250-A2 | ENTERIC COATED PHARMACEUTICAL FORMULATION | NORTON HEALTHCARE LIMITED (GB) | 2002-03-13 | — | — | EP | claimed |
| EP-1119348-A2 | ENTERIC COATED PHARMACEUTICAL FORMULATION | NORTON HEALTHCARE LIMITED (GB) | 2001-08-01 | — | — | EP | claimed |
| WO-2001051031-A2 | ENTERIC COATED PHARMACEUTICAL FORMULATION | NORTON HEALTHCARE LTD. (GB) | 2001-07-19 | — | — | WO | claimed |
| WO-2000001363-A2 | ENTERIC COATED PHARMACEUTICAL FORMULATION | NORTON HEALTHCARE LTD. (GB) | 2000-01-13 | — | — | WO | claimed |
| EP-0391518-B1 | SUSTAINED-RELEASE PHARMACEUTICAL PREPARATION | KINAFORM TECHNOLOGY, INC. (US) | 1993-09-29 | — | — | EP | claimed |
| EP-0457919-A1 | FUNCTIONAL FOOD | KABUSHIKI KAISYA ADVANCE (JP) | 1991-11-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250242031-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | SRI, SYNGR2, PSD | TSHR 4586/4885LMNA 3397/4885ALDH1A1 3898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.